Product Name

  • Name

    2-(4-Chlorophenoxy)-2-methylpropionic acid

  • EINECS 212-925-9
  • CAS No. 882-09-7
  • Article Data38
  • CAS DataBase
  • Density 1.265 g/cm3
  • Solubility
  • Melting Point 120-122 °C(lit.)
  • Formula C10H11ClO3
  • Boiling Point 324.1 °C at 760 mmHg
  • Molecular Weight 214.649
  • Flash Point 149.8 °C
  • Transport Information
  • Appearance pale yellow solid
  • Safety 36-24/25
  • Risk Codes 22-20/21/22
  • Molecular Structure Molecular Structure of 882-09-7 (2-(4-Chlorophenoxy)-2-methylpropionic acid)
  • Hazard Symbols HarmfulXn, IrritantXi
  • Synonyms (p-Chlorophenoxy)isobutyricacid;2-(4-Chlorophenoxy)-2-methylpropanoic acid;Clofibric acid;2-(p-Chlorophenoxy)-2-methylpropanoic acid;2-(p-Chlorophenoxy)-2-methylpropionic acid;2-(p-Chlorophenoxy)isobutyric acid;2-[(4-Chlorophenyl)oxy]-2-methylpropionic acid;4-Chlorophenoxyisobutyric acid;Arteriohom;CPIBA;Chlorfibrinic acid;Chlorofibrinic acid;Chlorophibrinic acid;Clofibrate free acid;Propionicacid, 2-(p-chlorophenoxy)-2-methyl- (6CI,7CI,8CI);
  • PSA 46.53000
  • LogP 2.58200

Synthetic route

ETOFIBRATE
31637-97-5

ETOFIBRATE

A

nicotinic acid
59-67-6

nicotinic acid

B

Clofibric acid
882-09-7

Clofibric acid

C

ethylene glycol
107-21-1

ethylene glycol

Conditions
ConditionsYield
With hydrogenchloride; [RuCl2(CO)2(Ph2P-3-C6H4COOH)2] In methanol; water at 75℃; for 0.333333h;A 99.1%
B n/a
C n/a
Clofibrate
637-07-0

Clofibrate

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With methanol; sodium hydroxide In dichloromethane; water94%
With sodium hydroxide In tetrahydrofuran; methanol; water93%
Stage #1: Clofibrate With lithium hydroxide monohydrate; water In tetrahydrofuran at 20℃; for 16h;
Stage #2: With hydrogenchloride In tetrahydrofuran pH=~ 2;
82%
4-chloro-phenol
106-48-9

4-chloro-phenol

1,1,1-trichloro-2-methyl-2-propanol
57-15-8

1,1,1-trichloro-2-methyl-2-propanol

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With sodium hydroxide In acetone for 16h; Ambient temperature;90%
2-bromo-2-methylpropionic acid
2052-01-9

2-bromo-2-methylpropionic acid

4-chloro-phenol
106-48-9

4-chloro-phenol

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
Stage #1: 4-chloro-phenol With sodium hydroxide In butanone at 50℃; for 1h;
Stage #2: 2-bromo-2-methylpropionic acid In butanone at 50℃; for 1.5h;
87%
With sodium hydroxide In ethanol for 24h; Heating;
Multistep reaction.;
Stage #1: 4-chloro-phenol With sodium hydroxide In butanone at 50℃; for 2h;
Stage #2: 2-bromo-2-methylpropionic acid In butanone at 50℃; for 12h;
acetamide
60-35-5

acetamide

1-bromo-methylenediamine

1-bromo-methylenediamine

O-(4-chlorophenyl)hydroxylamine
36637-30-6

O-(4-chlorophenyl)hydroxylamine

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With sodium sulfite In hexane at 65℃; for 2.16667h; Concentration; Temperature; Reflux;85%
N-acetylcystein
616-91-1

N-acetylcystein

clofibryl-S-acyl-glutathione

clofibryl-S-acyl-glutathione

A

Clofibric acid
882-09-7

Clofibric acid

B

clofibryl-S-acyl-N-acetylcysteine

clofibryl-S-acyl-N-acetylcysteine

Conditions
ConditionsYield
With buffer at 37℃; pH=7.4;A 1%
B 75%
chloroform
67-66-3

chloroform

4-chloro-phenol
106-48-9

4-chloro-phenol

acetone
67-64-1

acetone

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With sodium hydroxide for 0.416667h; grindstone chemistry;69%
With sodium hydroxide for 24h; Ambient temperature;59%
Stage #1: 4-chloro-phenol; acetone With sodium hydroxide at 20℃; for 0.5h; Reflux;
Stage #2: chloroform In acetone for 3.5h; Reflux;
Stage #3: With hydrogenchloride; water
Stage #1: 4-chloro-phenol; acetone at 20℃; for 0.0833333h;
Stage #2: With sodium hydroxide at 0℃;
Stage #3: chloroform for 5h; Reflux;
Stage #1: chloroform; 4-chloro-phenol; acetone With sodium hydroxide at 42 - 59℃; for 1.5h;
Stage #2: With hydrogenchloride pH=2;
ethyl 2-bromoisobutyrate
600-00-0

ethyl 2-bromoisobutyrate

sodium 4-chlorophenolate
1193-00-6

sodium 4-chlorophenolate

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With ethanol anschliessend Erwaermen mit wss. Natronlauge;
tetrachloromethane
56-23-5

tetrachloromethane

chloroform
67-66-3

chloroform

4-chloro-phenol
106-48-9

4-chloro-phenol

acetone
67-64-1

acetone

Clofibric acid
882-09-7

Clofibric acid

4-chloro-phenol
106-48-9

4-chloro-phenol

acetone
67-64-1

acetone

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With sodium hydroxide; chloroform
Duolip
54504-70-0

Duolip

A

Clofibric acid
882-09-7

Clofibric acid

B

7-(2-hydroxyethyl)theophylline
519-37-9

7-(2-hydroxyethyl)theophylline

Conditions
ConditionsYield
Product distribution; metabolism in vitro and in vivo in rats and dogs;
Clofibrate
637-07-0

Clofibrate

A

ethanol
64-17-5

ethanol

B

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With sodium hydroxide; water at 30.2℃; Rate constant; Product distribution; rate constant for hydrolysis, temperature and pH dependence;
ETOFIBRATE
31637-97-5

ETOFIBRATE

A

nicotinic acid
59-67-6

nicotinic acid

B

2-Hydroxyethyl nicotinate
3612-80-4

2-Hydroxyethyl nicotinate

C

Clofibric acid
882-09-7

Clofibric acid

D

2-(4-Chlorphenoxy)-2-methylpropionsaeure-2-hydroxyethylester
31637-96-4

2-(4-Chlorphenoxy)-2-methylpropionsaeure-2-hydroxyethylester

Conditions
ConditionsYield
With propylene glycol for 0.116667h; pharmacokinetics on intravenous infusion into dogs; other modes of administration, doses and formulations administered;
ETOFIBRATE
31637-97-5

ETOFIBRATE

A

2-Hydroxyethyl nicotinate
3612-80-4

2-Hydroxyethyl nicotinate

B

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With hydrogenchloride; water at 49.8℃; Rate constant; Product distribution; rate constant for hydrolysis, temperature and pH dependence;
Perifunal
63394-05-8

Perifunal

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With sodium hydroxide In water
2-(4-chloro-phenoxy)-2-methyl-propionic acid [methyl-(4-nitro-benzenesulfonyl)-amino]-methyl ester

2-(4-chloro-phenoxy)-2-methyl-propionic acid [methyl-(4-nitro-benzenesulfonyl)-amino]-methyl ester

A

Clofibric acid
882-09-7

Clofibric acid

B

4-chloro-N-hydroxymethyl-N-methyl-benzenesulfonamide

4-chloro-N-hydroxymethyl-N-methyl-benzenesulfonamide

Conditions
ConditionsYield
With sodium perchlorate; water In acetonitrile at 25℃; Rate constant; also in base and acid buffers;
2-(4-chloro-phenoxy)-2-methyl-propionic acid (benzoyl-ethoxycarbonylmethyl-amino)-methyl ester

2-(4-chloro-phenoxy)-2-methyl-propionic acid (benzoyl-ethoxycarbonylmethyl-amino)-methyl ester

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
With NADPH-generating system; rat liver homogenate at 37℃; Enzyme kinetics; Hydrolysis; Enzymatic reaction;
4-chloro-phenol
106-48-9

4-chloro-phenol

Clofibric acid
882-09-7

Clofibric acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: potassium carbonate / N,N-dimethyl-formamide / 0.17 h
1.2: 16 h / 20 °C
2.1: sodium hydroxide / tetrahydrofuran; methanol; water
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / N,N-dimethyl-formamide / 5 h / 30 - 70 °C
2: methanol; sodium hydroxide / dichloromethane; water
View Scheme
Clofibric acid
882-09-7

Clofibric acid

clofibryl chloride
5542-60-9

clofibryl chloride

Conditions
ConditionsYield
With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃;100%
With thionyl chloride; chloroform
With thionyl chloride
Clofibric acid
882-09-7

Clofibric acid

ephedrine
299-42-3

ephedrine

ephedrinium clofibrate
1234188-42-1

ephedrinium clofibrate

Conditions
ConditionsYield
Heating; Neat (no solvent);100%
Clofibric acid
882-09-7

Clofibric acid

benzyl alcohol
100-51-6

benzyl alcohol

α-(4-chloro-phenoxy)-isobutyric acid benzyl ester

α-(4-chloro-phenoxy)-isobutyric acid benzyl ester

Conditions
ConditionsYield
With [Cl(C6F13C2H4)2SnOSn(C2H4C6F13)2Cl]2 In various solvent(s) at 150℃; for 16h;98%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

Clofibric acid
882-09-7

Clofibric acid

2-(p-chlorophenoxy)-2-methyl-propionic acid succinimido ester
40249-24-9

2-(p-chlorophenoxy)-2-methyl-propionic acid succinimido ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In ethyl acetate95%
Clofibric acid
882-09-7

Clofibric acid

imino(methyl)(pyridin-2-yl)-λ6-sulfanone
76456-06-9

imino(methyl)(pyridin-2-yl)-λ6-sulfanone

N-[5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoyl]-S-methyl-S-2-pyridylsulfoximine
1384980-58-8

N-[5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoyl]-S-methyl-S-2-pyridylsulfoximine

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; for 12h; Inert atmosphere;95%
[(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid - (1R)-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one
869971-83-5

[(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid - (1R)-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one

Clofibric acid
882-09-7

Clofibric acid

(1R)-1'-[2-(4-Chlorophenoxy)-2-methylpropanoyl]-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one

(1R)-1'-[2-(4-Chlorophenoxy)-2-methylpropanoyl]-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In DMF (N,N-dimethyl-formamide) at 20℃;94%
Clofibric acid
882-09-7

Clofibric acid

4-amino-n-butyric acid
56-12-2

4-amino-n-butyric acid

C14H18ClNO4
1098392-92-7

C14H18ClNO4

Conditions
ConditionsYield
With chloroformic acid ethyl ester; triethylamine; sodium hydroxide In tetrahydrofuran; water at 20℃; for 1h; Cooling with ice salt bath;90%
Clofibric acid
882-09-7

Clofibric acid

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

2-(4-chlorophenoxy)-2-methylpropionic acid 3-bromopropyl ester

2-(4-chlorophenoxy)-2-methylpropionic acid 3-bromopropyl ester

Conditions
ConditionsYield
Stage #1: Clofibric acid With sodium hydroxide In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: 1,3-dibromo-propane In N,N-dimethyl-formamide at 70℃; for 5h;
90%
(3-bromopropyl)amine
18370-81-5

(3-bromopropyl)amine

Clofibric acid
882-09-7

Clofibric acid

C13H17BrClNO2

C13H17BrClNO2

Conditions
ConditionsYield
Stage #1: Clofibric acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.166667h;
Stage #2: (3-bromopropyl)amine In dichloromethane at 20℃;
90%
Clofibric acid
882-09-7

Clofibric acid

ethyl (R)-2-((mesitylsulfinyl)imino)acetate

ethyl (R)-2-((mesitylsulfinyl)imino)acetate

C22H28ClNO4S

C22H28ClNO4S

Conditions
ConditionsYield
With 9-mesityl-2,7-dimethyl-10-phenylacridin-10-ium tetrafluoroborate; potassium carbonate at 20℃; Inert atmosphere; Irradiation; diastereoselective reaction;90%
2-bromoethylamine
107-09-5

2-bromoethylamine

Clofibric acid
882-09-7

Clofibric acid

C12H15BrClNO2

C12H15BrClNO2

Conditions
ConditionsYield
Stage #1: Clofibric acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.166667h;
Stage #2: 2-bromoethylamine In dichloromethane at 20℃;
89%
methanol
67-56-1

methanol

Clofibric acid
882-09-7

Clofibric acid

2-[4-chlorophenoxy]-2-methylpropionic acid methyl ester
55162-41-9

2-[4-chlorophenoxy]-2-methylpropionic acid methyl ester

Conditions
ConditionsYield
With sulfuric acid for 6h; Heating;88%
With pyridine; thionyl chloride 1.) ether, reflux, 90 min; 2.) 60 min; Yield given. Multistep reaction;
Clofibric acid
882-09-7

Clofibric acid

ethylene dibromide
106-93-4

ethylene dibromide

2-(4-chlorophenoxy)-2-methylpropionic acid 2-bromoethyl ester

2-(4-chlorophenoxy)-2-methylpropionic acid 2-bromoethyl ester

Conditions
ConditionsYield
Stage #1: Clofibric acid With sodium hydroxide In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: ethylene dibromide In N,N-dimethyl-formamide at 70℃; for 5h;
88%
1,3-bis(2,2-dimethyl-1,3-dioxan-5-yloxy)propan-2-yl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate
847682-00-2

1,3-bis(2,2-dimethyl-1,3-dioxan-5-yloxy)propan-2-yl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate

Clofibric acid
882-09-7

Clofibric acid

1,3-bis(2,2-dimethyl-1,3-dioxan-5-yloxy)propan-2-yl 2-(4-chlorophenoxy)-2-methylpropanoate
1043468-93-4

1,3-bis(2,2-dimethyl-1,3-dioxan-5-yloxy)propan-2-yl 2-(4-chlorophenoxy)-2-methylpropanoate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 2h; Inert atmosphere;87%
4-boc-aminopiperidine

4-boc-aminopiperidine

Clofibric acid
882-09-7

Clofibric acid

tert-butyl (1-(2-(4-chlorophenoxy)-2-methylpropanoyl)piperidin-4-yl)carbamate

tert-butyl (1-(2-(4-chlorophenoxy)-2-methylpropanoyl)piperidin-4-yl)carbamate

Conditions
ConditionsYield
Stage #1: Clofibric acid With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 2h; Cooling with ice;
Stage #2: 4-boc-aminopiperidine With triethylamine In dichloromethane at 20℃; for 1h; Cooling with ice;
86%
Clofibric acid
882-09-7

Clofibric acid

ethyl acrylate
140-88-5

ethyl acrylate

C16H17F3O5

C16H17F3O5

Conditions
ConditionsYield
With tert-Amyl alcohol; t-Boc-L-valine; oxygen; palladium diacetate; potassium hydrogencarbonate at 90℃; for 24h; Schlenk technique;85%
1,4-dibromo-butane
110-52-1

1,4-dibromo-butane

Clofibric acid
882-09-7

Clofibric acid

2-(4-chlorophenoxy)-2-methylpropionic acid 4-bromobutyl ester

2-(4-chlorophenoxy)-2-methylpropionic acid 4-bromobutyl ester

Conditions
ConditionsYield
Stage #1: Clofibric acid With sodium hydroxide In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: 1,4-dibromo-butane In N,N-dimethyl-formamide at 70℃; for 5h;
83%
Clofibric acid
882-09-7

Clofibric acid

1-t-Butoxycarbonylpiperazine
57260-71-6

1-t-Butoxycarbonylpiperazine

C19H27ClN2O4

C19H27ClN2O4

Conditions
ConditionsYield
Stage #1: Clofibric acid With 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 70℃; for 1h;
Stage #2: 1-t-Butoxycarbonylpiperazine In N,N-dimethyl-formamide for 2h;
83%
triethanolamine
102-71-6

triethanolamine

Clofibric acid
882-09-7

Clofibric acid

2-(4-Chloro-phenoxy)-2-methyl-propionic acid; compound with 2-[bis-(2-hydroxy-ethyl)-amino]-ethanol
105377-53-5

2-(4-Chloro-phenoxy)-2-methyl-propionic acid; compound with 2-[bis-(2-hydroxy-ethyl)-amino]-ethanol

Conditions
ConditionsYield
In ethanol81.8%
1-bromo-4-aminobutane
33977-38-7

1-bromo-4-aminobutane

Clofibric acid
882-09-7

Clofibric acid

C14H19BrClNO2

C14H19BrClNO2

Conditions
ConditionsYield
Stage #1: Clofibric acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.166667h;
Stage #2: 4-bromo-1-aminobutane In dichloromethane at 20℃;
81%
Clofibric acid
882-09-7

Clofibric acid

benzyl salicylate
118-58-1

benzyl salicylate

benzyl O-<2-(p-chlorophenoxy)-2-methylpropionyl>salicylate
90296-25-6

benzyl O-<2-(p-chlorophenoxy)-2-methylpropionyl>salicylate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane Ambient temperature;78%
2-thiazolylamine
96-50-4

2-thiazolylamine

Clofibric acid
882-09-7

Clofibric acid

2-(4-chloro-phenoxy)-2-methyl-N-thiazol-2-yl-propionamide
404360-27-6

2-(4-chloro-phenoxy)-2-methyl-N-thiazol-2-yl-propionamide

Conditions
ConditionsYield
Stage #1: Clofibric acid With benzotriazol-1-ol; triethylamine In dichloromethane at 0℃; for 0.0833333h;
Stage #2: 2-thiazolylamine With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 12h;
78%
trifluoroethylamine
753-90-2

trifluoroethylamine

Clofibric acid
882-09-7

Clofibric acid

acetonitrile
75-05-8

acetonitrile

N-acetyl-2-(4-chlorophenoxy)-2-methyl-N-(2,2,2-trifluoroethyl)propanamide

N-acetyl-2-(4-chlorophenoxy)-2-methyl-N-(2,2,2-trifluoroethyl)propanamide

Conditions
ConditionsYield
With copper(l) iodide; tert.-butylnitrite at 25℃; for 12h; chemoselective reaction;78%
Clofibric acid
882-09-7

Clofibric acid

19-O-tritylisoandrographolide

19-O-tritylisoandrographolide

C49H53ClO7

C49H53ClO7

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;76%
N-hydroxyphthalimide
524-38-9

N-hydroxyphthalimide

Clofibric acid
882-09-7

Clofibric acid

1,3-dioxoisoindolin-2-yl 2-(4-chlorophenoxy)-2-methylpropanoate

1,3-dioxoisoindolin-2-yl 2-(4-chlorophenoxy)-2-methylpropanoate

Conditions
ConditionsYield
With dmap; diisopropyl-carbodiimide In dichloromethane at 20℃; for 1h;76%
With dmap; dicyclohexyl-carbodiimide at 20℃; for 6h; Schlenk technique; Inert atmosphere;

2-(4-Chlorophenoxy)-2-methylpropionic acid Chemical Properties

Molecule structure of Clofibric acid (CAS NO.882-09-7):
 
IUPAC Name: 2-(4-Chlorophenoxy)-2-methylpropanoic acid 
Molecular Weight: 214.64554 g/mol
Molecular Formula: C10H11ClO3
Density: 1.265 g/cm3 
Melting Point: 120-122 °C(lit.)
Boiling Point: 324.1 °C at 760 mmHg 
Flash Point: 149.8 °C
Index of Refraction: 1.54
Molar Refractivity: 53.25 cm3
Molar Volume: 169.5 cm3
Polarizability: 21.11×10-24 cm3
Surface Tension: 43.7 dyne/cm 
Enthalpy of Vaporization: 59.76 kJ/mol
Vapour Pressure: 0.000103 mmHg at 25 °C 
Water Solubility: 583 mg/L
XLogP3: 2.6
H-Bond Donor: 1
H-Bond Acceptor: 3
Rotatable Bond Count: 3
Exact Mass: 214.039672
MonoIsotopic Mass: 214.039672
Topological Polar Surface Area: 46.5
Heavy Atom Count: 14
Complexity: 207
Canonical SMILES: CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl
InChI: InChI=1S/C10H11ClO3/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6H,1-2H3,(H,12,13)
InChIKey: TXCGAZHTZHNUAI-UHFFFAOYSA-N
EINECS: 212-925-9
Product Categories: Acids and Derivatives; Organic acids; Aromatics Compounds; Aromatics; Intermediates & Fine Chemicals; Pharmaceuticals; Intracellular receptor

2-(4-Chlorophenoxy)-2-methylpropionic acid Uses

 Clofibric acid (CAS NO.882-09-7) is used as intermediates for pharmaceutical Clofibrate. It also functions as a plant growth regulator against the plant hormone auxin.

2-(4-Chlorophenoxy)-2-methylpropionic acid Toxicity Data With Reference

1.    

dns-rat-orl 2100 mg/kg/1W-C

    CRNGDP    Carcinogenesis. 12 (1991),1557.
2.    

unk-hmn TDLo:260 mg/kg (91D):LIV

    ATHSBL    Atherosclerosis (Shannon, Ireland). 36 (1980),159.
3.    

orl-rat LD50:897 mg/kg

    ARZNAD    Arzneimittel-Forschung. Drug Research. 30 (1980),2023.
4.    

scu-rat LD50:120 mg/kg

    PHARAT    Pharmazie. 22 (1967),167.
5.    

orl-mus LD50:1170 mg/kg

    ARZNAD    Arzneimittel-Forschung. Drug Research. 27 (1977),1173.
6.    

ipr-mus LD50:290 mg/kg

    PHARAT    Pharmazie. 22 (1967),167.
7.    

scu-mus LD50:683 mg/kg

    RPTOAN    Russian Pharmacology and Toxicology. Translation of FATOAO. 33 (1970),150.

2-(4-Chlorophenoxy)-2-methylpropionic acid Safety Profile

Hazard Codes: HarmfulXn, IrritantXi
Risk Statements: 22-20/21/22 
R22:Harmful if swallowed. 
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 36-24/25 
S36:Wear suitable protective clothing. 
S24/25:Avoid contact with skin and eyes.
WGK Germany: 3
RTECS: UE9455000
Hazard Note: Irritant
HazardClass: IRRITANT
Poison by intraperitoneal and subcutaneous routes. Moderately toxic by ingestion. Liver damage in humans by an unspecified route. Mutation data reported. When heated to decomposition it emits toxic fumes of Cl.

2-(4-Chlorophenoxy)-2-methylpropionic acid Specification

 Clofibric acid (CAS NO.882-09-7) is also named as 2-(4-Chlorophenoxy)-2-methylpropanoic acid ; 2-(4-Chlorophenoxy)-2-methylpropionic acid ; 2-(p-Chlorophenoxy)-2-methylpropionic acid ; 2-(p-Chlorophenoxy)isobutyric acid ; 4-(Chlorophenoxy)isobutyric acid (VAN) ; 4-06-00-00851 (Beilstein Handbook Reference) ; Acetic acid, (p-chlorophenoxy)dimethyl- ; Acide (p-chlorophenoxy)-2 methyl-2 propionique ; Acide (p-chlorophenoxy)-2 methyl-2 propionique [French] ; Acide clofibrique ; Acide clofibrique [INN-French] ; Acido clofibrico ; Acido clofibrico [INN-Spanish] ; Acidum chlorphibricum ; Acidum clofibricum ; Acidum clofibricum [INN-Latin] ; BRN 1874067 ; CCRIS 9254 ; Chlorfibrinic acid ; Chlorofibrinic acid ; Chlorophibrinic acid ; Clofibrate free acid ; Clofibrin ; Clofibrinsaeure ; Clofibrinsaeure [German] ;
NSC 1149 ; Regadrin ; Regulipid ; UNII-53PF01Q249 ; alpha-(4-(Chlorphenoxy)-2-methylpropionsaeure ; alpha-(4-Chlorophenoxy)-alpha-methylpropionic acid ; alpha-(4-Chlorophenoxy)isobutyric acid ; alpha-(p-Chlorophenoxy)isobutyric acid ; p-(2,4-Chlorophenoxy)isobutyric acid . Clofibric acid (CAS NO.882-09-7) is pale yellow solid.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View